Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
University of California, Irvine
University of California, Irvine
Rutgers, The State University of New Jersey
SCRI Development Innovations, LLC
Eli Lilly and Company
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
SWOG Cancer Research Network
Roswell Park Cancer Institute
Institut du Cancer de Montpellier - Val d'Aurelle
Gruppo Oncologico del Nord-Ovest
UNICANCER
NuCana plc
IFOM ETS - The AIRC Institute of Molecular Oncology
Memorial Sloan Kettering Cancer Center
Pfizer
UNC Lineberger Comprehensive Cancer Center
NuCana plc
Charite University, Berlin, Germany
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Fudan University
Fudan University
UNC Lineberger Comprehensive Cancer Center
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Hôpital Franco-Britannique-Fondation Cognacq-Jay
Shanghai Zhongshan Hospital
Sun Yat-sen University
Institut Bergonié
University of Leeds
NSABP Foundation Inc
GERCOR - Multidisciplinary Oncology Cooperative Group
Memorial Sloan Kettering Cancer Center
China Medical University, China
Fox Chase Cancer Center
UNICANCER
UNICANCER
UNICANCER
SillaJen, Inc.
American College of Radiology Imaging Network
Federation Francophone de Cancerologie Digestive
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Chicago
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Federation Francophone de Cancerologie Digestive